Source: FiercePharma

Teligent: Teligent, Edge Pharma yank meds on superpotency, sterility concerns

Teligent, Edge Pharma yank meds on superpotency, sterility concerns fkansteiner Wed, 12/08/2021 - 09:05

Read full article »
Teligent's Competitors | Teligent's News | Teligent's Financials
Stay up-to-date with the latest news on Teligent
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Tim Sawyer's photo - President & CEO of Teligent

President & CEO

Tim Sawyer

CEO Approval Rating

89/100

Read more
Stay up-to-date with the latest news on Teligent